Iovance Biotherapeutics Inc. buy Wells Fargo & Company
Start price
30.05.23
/
50%
€7.97
Target price
30.05.24
€15.85
Performance (%)
32.49%
Price
19:51
€10.57
Summary
This prediction is currently active. With a performance of 32.49% the BUY prediction by Wells_Fargo___Compan is a big success. This prediction currently runs until 30.05.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | -10.456% | -10.456% |
| iShares Core DAX® | -1.670% | -1.001% |
| iShares Nasdaq 100 | -4.184% | -1.145% |
| iShares Nikkei 225® | -4.967% | -5.783% |
| iShares S&P 500 | -2.834% | -0.572% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $17.00 price target on the stock, up previously from $11.00.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€11.70
20.02.24
20.02.24
€20.35
20.02.25
20.02.25
-10.73%
19:51
19:51
